| Literature DB >> 33832143 |
Kaiyong Liang1, Qiao Xie2, Jieping Nie1, Jieqing Deng1.
Abstract
BACKGROUND: Insulin is an essential therapy for treating diabetes, but many patients lack standard insulin injection skills.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33832143 PMCID: PMC8036090 DOI: 10.1097/MD.0000000000025424
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1The study design.
questionare for evaluating insulin injection tequniques.
| Questions | Score (yes = 1; no = 0) |
| 1. Disinfection preparation | Yes/no |
| 2. Wash hands before injection | Yes/no |
| 3. The details of keeping the spare cartridge or insulin pen | Yes/no |
| 4. Insulin pen matches right insulin cartidge | Yes/no |
| 5. Cartridge and needle are installed correctly | Yes/no |
| 6. Make sure the insulin can be drained after changing the cartridge | Yes/no |
| 7. Shake insulin before injection (for premixed insulin) | Yes/no |
| 8. Knowing the right body injection sites | Yes/no |
| 9. Rotating the sites for injection | Yes/no |
| 10. Each injection site is separated by 1 cm at least | Yes/no |
| 11. Ejecting the excess air away before each injection | Yes/no |
| 12. Changing a new needle for each injection | Yes/no |
| 13. Injection dose adjustment | Yes/no |
| 14. Grasping the injection site in the proper position during injection | Yes/no |
| 15. Correct injection angle | Yes/no |
| 16. Whether the posture of holding the insulin pen is correct | Yes/no |
| 17. After penetrating the skin, pushing the injector piston correctly | Yes/no |
| 18. Removing the needle after right time | Yes/no |
| 19. After the needle is pulled, the injection site is pressed correctly (by cotton swab) | Yes/no |
| 20. Removing the needle with the same penetration angle. | Yes/no |
Figure 2Structure diagram of improved simulation tool.
Figure 4The patient wears this simulation model.
Two training strategies.
| Standard training procedure | Traditional training procedure |
| Step1: Simple teaching stage with simulation tools | Step1: Simple teaching stage without simulation tools |
| Step2: Detailed teaching stage with simulation tools | Step2: Detailed teaching stage without simulation tools |
| Step3: Review with manual, videos and simulation tools | Step3: Review with manual and videos not simulation devices |
| Step4: Manuals and videos are provided to review after leaving the hospital | Step4: Manuals and videos are provided to review after leaving the hospital |
Participant characteristics.
| Statistics N | Group C 60 cases | Group T 60 cases | ||
| Age, y | Mean ± SD, range | 59.47 ± 13.07 18–82 | 57.45 ± 12.35 27–81 | |
| Age distribution, y | ||||
| <18 | n (%) | 1 (1.7) | 0 | K = 1.574 |
| 18–40 | n (%) | 5 (8.3) | 7 (11.7) | |
| 40–65 | n (%) | 32 (53.3) | 34 (56.7) | |
| ≥65 | n (%) | 22 (36.7) | 19 (31.7) | |
| Sex | ||||
| Male | n (%) | 27 (45) | 30 (50.0) | K = 0.301 |
| female | n (%) | 33 (55) | 30 (50.0) | |
| Type of diabetes | ||||
| Type 2 diabetes | n (%) | 58 (96.7) | 60 (100) | |
| Pregnancy with diabetes | n (%) | 2 (3.3) | No | |
| Duration of diabetes | Median (IQR) | 3 yrs (7 d, 30 yrs) | 2.5yrs (7d,8.75yrs) | |
| Overview | Range | 7 d–30 yrs | 7d–30yrs | |
| <1 y | n (%) | 16 (26.7) | 21 (35) | |
| 1–5 y | n (%) | 21 (35) | 17 (28.3) | |
| 6–10 y | n (%) | 12 (20.0) | 14 (23.3) | |
| 11–20 y | n (%) | 10 (16.6) | 7 (11.7) | |
| Above 20 y | n (%) | 1 (1.7) | 1 (1.7) | |
| Educational status | ||||
| Primary school or less | n (%) | 15 (25.0) | 16 (26.7) | |
| Junior high school | n (%) | 20 (33.3) | 19 (31.7) | K = 1.467 |
| Technical secondary school | n (%) | 4 (6.7) | 5 (8.3) | |
| High school | n (%) | 12 (20.0) | 14 (23.3) | |
| College | n (%) | 6 (10.0) | 5 (8.3) | |
| University graduate or more | n (%) | 3 (5.0) | 1 (1.7) | |
| Occupation | ||||
| Worker | n (%) | 42 (70.0) | 46 (76.7) | |
| Farmer | n (%) | 7 (11.7) | 5 (8.3) | |
| Retired | n (%) | 10 (16.7) | 6 (10.0) | |
| Student | n (%) | 1 (1.7) | No | |
| Self-employed | n (%) | No | 3 (5.0) | |
| Insulin pen syringe combination | ||||
| Gansulin pen | n (%) | 17 (28.3) | 15 (25.0) | |
| Novo Pen 4 | n (%) | 40 (66.7) | 43 (71.7) | |
| Novo Pen 4+ Clikstar | n (%) | 3 (5.0) | No | |
| Gansulin pen+ Novo Pen 4 | n (%) | No | 2 (3.3) | |
| Treatment of insulin | ||||
| 30/70 Mixture recombinant human insulin | n (%) | 16 (26.7) | 15 (25.0) | |
| Insulin aspartame 30/70 | n (%) | 37 (61.7) | 39 (65.0) | |
| Rapid-effect insulin + basal insulin | n (%) | 2 (3.3) | 0 (0) | |
| Short-acting insulin + basal insulin | n (%) | 5 (8.3) | 6 (10.0) | |
| Frequency of insulin injections | ||||
| Twice | n (%) | 24 (40.0) | 21 (35.0) | |
| 3 Times | n (%) | 29 (48.3) | 34 (56.7) | |
| 4 times | n (%) | 7 (11.7) | 5 (8.3) | |
| Insulin dosage, U | Median (25/75 percentile) range | 24 (18, 33) 7–54 | 24 (18.25, 29.5) 8–44 | Nonparametric test Z = 0.639 |
| Whether family member help to inject insulin as an agent | ||||
| Yes | n (%) | 12 (80.0) | 9 (15.0) | |
| No | n (%) | 48 (20.0) | 51 (85.0) | K = 0.519 |
IQR = interquartile range.
Comparison between the 2 groups.
| Group C (control) | Group T (trial) | |||
| cases | 60 | 60 | ||
| Time at simple teaching, min | 6 (4,8) | 5.5 (4,8) | −0.884 | .377 |
| Time at detailed teaching, min | 10 (8,13) | 8 (6,11) | −3.278 | .001 |
| Time for mastery, min | 16 (13,18) | 10 (8,13) | −7.541 | .000 |
| Success rate of the first actual subcutaneous operation | 28 (60) 46.67% | 44 (60) 73.33% | 10.375 | .006 |
| Score in first real subcutaneous operation (points) | 12 (11,14) | 18 (16,19) | −9.457 | .000 |
| Time required for once insulin injection, min | 2.45 (1.8,2.98) | 2.00 (1,2) | −6.146 | .000 |
| Score at pre-discharge (points) | 13 (11,15) | 18 (16,19) | −9.061 | .000 |
| Score at 1 month after discharge (points) | 13 (12,15) | 18 (17,19) | −9.226 | .000 |
| Rate of subcutaneous fat hyperplasia | 9 (60) 15.0% | 2 (60) 3.3% | 4.904 | .027 |
| Rate of hypoglycemia | 16 (60) 26.7% | 10 (60) 16.7% | 1.768 | .184 |
| Z = −3.274<!-—<LBREAK"/>-->∗ | Z = −3.071<!-—<LBREAK"/>-->∗ |
P indicates the comparison of the indicators of both groups before and after discharge.
Figure 5Human abdomen model (1 piece of silicone).
Figure 6The small device designed by some company.